aTyr Pharma, Inc. (ATYR) vs BeyondSpring Inc. (BYSI)

A side-by-side comparison of aTyr Pharma, Inc. and BeyondSpring Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ATYR

aTyr Pharma, Inc.

$28M

$0.29HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BYSI

BeyondSpring Inc.

$32M

$0.79HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ATYR vs BYSI

growth of $100 · dividends reinvested · last 2y

ATYR -83.2% (-59.1%/yr)BYSI -71.0% (-46.1%/yr)BYSI compounded faster over this window

ATYR BYSI

ATYR vs BYSI: by the numbers

•BYSI is the larger company ($32M vs $28M market cap).
•Both run net losses; BYSI's is the smaller (0.00% vs -32003.68% net margin).

Metrics side by side

Valuation

Metric	ATYR	BYSI
P/S ratio	149.66	N/A
P/B ratio	0.58	N/A

Profitability

Metric	ATYR	BYSI
Gross margin	-717.37%	0.00%
Operating margin	-40856.32%	0.00%
Net margin	-32003.68%	0.00%
ROE	-124.64%	N/A
ROIC	-109.29%	N/A

Growth (annualized)

Metric	ATYR	BYSI
Revenue CAGR (5Y)	-38.74%	N/A
Total return CAGR (5Y)	N/A	-44.30%

Go deeper

Full ATYR analysis Full BYSI analysis Interactive comparison tool

Dig into the metrics

aTyr Pharma ROE BeyondSpring ROE aTyr Pharma operating margin BeyondSpring operating margin aTyr Pharma revenue growth BeyondSpring revenue growth aTyr Pharma free cash flow BeyondSpring free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.